Doctor, don’t let your patient be your training model

Medical Simulation Technologies Sp. z o.o. (MST) was established for the commercialization of advanced medical simulators, especially in the training of cardiologists. The technology that we provide results from many years of research. The key to our success is an open mind and a team of professionals, which is why our company is created from a multidisciplinary group of experts: programmers, hardware specialists, medical practitioners and business development specialists. We believe this gives us the advantage of innovation, quality, and focus on practical solutions.

Heart failure, or generally cardiovascular disease is still the leading cause of death for both men and women. Overall quality of examination, proper diagnosis and heart surgery success rate could be greatly improved in case if the physicians train more their practical skills. The simulation platform dedicated for echocardiography examination and minimally invasive heart intervention training, which is bases of our business, could be one of the most important tool in students and physicians practical training. In opposite to every other heart simulator presents in the market, MST has developed the simulation platform based on a heart model from computed tomography (CT) of real patient. Thanks to that, a user can practice on the most realistic heart models with numerous pathologies and have the feeling of real examination or surgery.

Our motto is: Doctor, don’t let your patient be your training model!

MST’s devices are composed of light and mobile hardware (a phantom and TEE probe) connected to a regular PC by USB cable, advanced software and 3D visualization specifically prepared for the CT scan dataset. The screen interface shows not only 2D cross-sections similar to TEE images but also the components of the probe motion (probe depth, bends and rotation) as well as the angle of the imaging plane. Another advantage is a biplane option showing two simultaneous sections steered independently – as in contemporary 3D echo machines.

We have already started the sale process in the US, which is our beach-head market (our first simulator was already implemented at Columbia University in New York City, another one will be delivered in a few months). The next step will be the emphasis on simulator sales in the European market, especially in the most promising countries such as Germany, France, GB, Italy, Netherlands, Poland and Spain.

Currently, in Europe and USA minimally invasive heart surgery is replacing open-heart surgery method. Such a trend requires the development of innovative training methods for physicians. The total market of dedicated heart surgery simulator is forecast to reach $2.27 billion by year 2021 (

Performing heart surgery using the latest laparoscopic techniques is difficult even for experienced physicians due to limited view of a structure to be repaired, tools used for surgery and the fact that the treatment is done on a beating heart.

Therefore we’ve decided to adapt our medical simulation platform for microinvasive treatment. The result of this decision was the collaboration with med-tech company from USA introducing new methods of micro invasive heart surgery of mitral valve.

MST also has been conducted for the 4 years dozens of workshops for Polish cardiologists in the field of transesophageal echocardiography examination in cooperation with pharmaceutical companies. Over 1000 cardiac specialists have taken part in our workshops across the country.

The company’s efforts have been recognized and it has become a laureate of prestigious awards, including first place in the EIT Health GoEurope Contest in 2016, second place in the Digital Healthcare Contest in the EIT Health Catapult competition in Brussels (July 2017), or third place at The Digital Healthcare Hackaton in Gdańsk (Poland) (May 2017). MST was also a semi-finalist in the competition for the best European companies in the field of Digital Healthcare at EIT Health Catapult in Brussels (September 2017) and a finalist of the MIT Enterprise Forum Poland program (July 2017). In March 2018, the company was awarded a special prize and a distinction in the Polish Product of the Future competition for the TEE study, organized by the Polish Agency for Enterprise Development, and in May 2018 the second place in the Top Trends competition in CEE countries.


The company has successfully established cooperation many medical institutions around the world. The collaboration includes internationally renowned institutions such as Columbia University of New York, USA and the Cadiovascular Research Foundation in the US. The company also cooperates with Polish educational institutions such as the Jagiellonian University and John Paul II Hospital in Cracow, Poland and with the Medical University of Gdańsk, Gdańsk, Poland. Support was also gained from one of the world’s leaders in echocardiography, prof. Rebecca Hahn. Representatives of MST visited Boston in June 2017 (with a special focus on MIT), New York City (in July 2017, April 2018) and Chicago (TVT, June 2018) to look for further contacts with people who can support us in the process of promoting and selling our simulators. MST in the past few months also gained as a new clients large companies in the medical industry such as: Abbott and Edwards Lifescences.

MST has also been invited to the 2018 Industry Think Tank & IRT organized by the American Society of Echocardiography in April 2018 in NYC.

The company is looking for a strategic partner, preferably in the field of med-tech with experience in capital investments, for which the field of medical simulation would be an interesting addition to the portfolio of its products.

Other offers:

  • MST is looking for partners / partners to distribute and sell simulators in different countries of the world.
  • MST is seeking cooperation with simulation centers on the use of simulators on a sale / lease basis.
  • MST is seeking cooperation with hospitals and specialized companies in providing CT images of the heart.
  • MST is seeking cooperation with med-tech companies for the development and deployment of further simulators in the Medical Simulation Technologies series.
The nature of the expected cooperation